Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Teak leaf extract can help treat hair loss, and its effectiveness varies by geographic origin.

The document's conclusion cannot be provided because the document is not available or cannot be read.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Oxidative stress contributes to alopecia areata, suggesting antioxidant treatments might help.

Mice without certain skin enzymes have faster hair growth and bigger eye glands.

Women also use 5α-reductase inhibitors, and their effects differ from men.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Store Tectona grandis leaf extracts in slightly acidic, light-protected conditions for best stability.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

ALDOA levels drop in hair cells during hair loss.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.